Dr Luke Baker

Research Associate - Muscle Biology in Chronic Disease

School/Department: Respiratory Sciences, Department of

Telephone: +44 (0)116 252 5033



I joined the University of Leicester in 2018 as part of the Leicester Kidney Lifestyle Team (LKLT) and have subsequently moved over to the Leicester Biomedical Research Centre (BRC) to support cross theme research around muscle biology in those with chronic disease. My research centres around understanding the mechanisms which contribute to muscle loss and dysfunction in those with multiple long term conditions (MLTCs), with a particular focus on how the onset and resolution of inflammation contributes to the endotypes noted in patient populations. I use a translational 'bench-to-bedside' approach in order to uncover therapeutic targets and develop subsequent interventions for patient benefit.


My research interests are in line with the below themes:

  • Disease induced skeletal muscle loss & dysfunction
  • Mechanisms of resolution physiology (production & function)
  • Patient specific cellular modelling
  • Biological definitions of skeletal muscle presentation
  • Biomarkers of disease progression
  • 'Muscle-organ' crosstalk

Patient populations of interest:

  • Multiple long term conditions (MLTCs)
  • Chronic Kidney Disease (CKD)
  • Type 2 Diabetes (T2DM)
  • Chronic Obstructive Pulmonary Disease (COPD)
  • 'Long COVID-19'



Recent selected publications:

Baker, L. A., March, D. S., Wilkinson, T. J., Billany, R. E., Bishop, N. C., Castle, E. M., ... & Burton, J. O. (2022). Clinical practice guideline exercise and lifestyle in chronic kidney disease. BMC nephrology23(1), 1-36.

Wilkinson, T. J., Yates, T., Baker, L. A., Zaccardi, F., & Smith, A. C. (2022). Sarcopenic obesity and the risk of hospitalization or death from coronavirus disease 2019: findings from UK Biobank. JCSM rapid communications5(1), 3-9.

Baker, L. A., O'Sullivan, T. F., Robinson, K. A., Graham‐Brown, M. P., Major, R. W., Ashford, R. U., ... & Watson, E. L. (2021). Primary skeletal muscle cells from chronic kidney disease patients retain hallmarks of cachexia in vitro. Journal of Cachexia, Sarcopenia and Muscle.

Watson, E. L., Baker, L. A., Wilkinson, T. J., Gould, D. W., Xenophontos, S., Graham-Brown, M., ... & Smith, A. C. (2021). Inflammation and physical dysfunction: responses to moderate intensity exercise in chronic kidney disease. Nephrology Dialysis Transplantation.

Wilkinson, T. J., Miksza, J., Yates, T., Lightfoot, C. J., Baker, L. A., Watson, E. L., ... & Smith, A. C. (2021). Association of sarcopenia with mortality and end‐stage renal disease in those with chronic kidney disease: a UK Biobank study. Journal of cachexia, sarcopenia and muscle12(3), 586-598.

Watson, E. L., Baker, L. A., Wilkinson, T. J., Gould, D. W., Graham‐Brown, M. P., Major, R. W., ... & Smith, A. C. (2020). Reductions in skeletal muscle mitochondrial mass are not restored following exercise training in patients with chronic kidney disease. The FASEB Journal34(1), 1755-1767.

Capel, A. J., Rimington, R. P., Fleming, J. W., Player, D. J., Baker, L. A., Turner, M. C., ... & Lewis, M. P. (2019). Scalable 3D printed molds for human tissue engineered skeletal muscle. Frontiers in bioengineering and biotechnology7, 20.

Baker, L. A., Martin, N. R., Kimber, M. C., Pritchard, G. J., Lindley, M. R., & Lewis, M. P. (2018). Resolvin E1 (RvE1) attenuates LPS induced inflammation and subsequent atrophy in C2C12 myotubes. Journal of Cellular Biochemistry119(7), 6094-6103.



In line with my research interests I supervise laboratory based PhD, iMSc, MSc and BSc projects from a range of course offered at UoL.

Press and media

Get in touch for media enquiries, expert opinion, interviews, images or videos.
Back to top